Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

News

News
09/12/2022

Yvette C Terrie

Yvette C Terrie
General physicians and other providers are progressively referring patients requiring cerumen disimpaction to otolaryngologist physicians and permitting advanced practice providers to perform these procedures, suggesting a shift in landscape...
General physicians and other providers are progressively referring patients requiring cerumen disimpaction to otolaryngologist physicians and permitting advanced practice providers to perform these procedures, suggesting a shift in landscape...
General physicians and other...
09/12/2022
Journal of Clinical Pathways
News
09/01/2022

Yvette C Terrie

Yvette C Terrie
Nursing model intervention established on Rosenthal effect may improve the self-efficacy and meaning of life in patients with non-small cell lung cancer, and diminish the negative emotions and self-burden.
Nursing model intervention established on Rosenthal effect may improve the self-efficacy and meaning of life in patients with non-small cell lung cancer, and diminish the negative emotions and self-burden.
Nursing model intervention...
09/01/2022
Journal of Clinical Pathways
News
09/01/2022

Yvette C Terrie

Yvette C Terrie
Findings from a recent cross-sectional study of national cancer care expenditures and cancer mortality rates across 22 high-income countries indicate that although the cancer mortality rate in the US was lower than the median, the US spent...
Findings from a recent cross-sectional study of national cancer care expenditures and cancer mortality rates across 22 high-income countries indicate that although the cancer mortality rate in the US was lower than the median, the US spent...
Findings from a recent...
09/01/2022
Journal of Clinical Pathways
News
08/26/2022

Yvette C Terrie

Yvette C Terrie
Amy McKee, MD, Head of Regulatory Oncology, Parexel, and Alex Gee, Senior Director, Pricing and Market Access, Parexel, provided information about recent advancements in evidence needed to support oncology drug development and shared insights...
Amy McKee, MD, Head of Regulatory Oncology, Parexel, and Alex Gee, Senior Director, Pricing and Market Access, Parexel, provided information about recent advancements in evidence needed to support oncology drug development and shared insights...
Amy McKee, MD, Head of...
08/26/2022
Journal of Clinical Pathways
News
08/26/2022

Yvette C Terrie

Yvette C Terrie
In a recent press release, the top global life sciences company, Labcorp, announced its decision from its Board of Directors to move forward with a spinoff of the company’s wholly owned Clinical Development business to shareholders of Labcorp...
In a recent press release, the top global life sciences company, Labcorp, announced its decision from its Board of Directors to move forward with a spinoff of the company’s wholly owned Clinical Development business to shareholders of Labcorp...
In a recent press release, the...
08/26/2022
Journal of Clinical Pathways
News
08/26/2022

Yvette C Terrie

Yvette C Terrie
In a recent press release, the Centers for Medicare and Medicaid Services (CMS) announced that the average basic monthly premium for standard Medicare Part D coverage is predicted to be nearly $31.50 in 2023, a reduction of 1.8% from $32.08...
In a recent press release, the Centers for Medicare and Medicaid Services (CMS) announced that the average basic monthly premium for standard Medicare Part D coverage is predicted to be nearly $31.50 in 2023, a reduction of 1.8% from $32.08...
In a recent press release, the...
08/26/2022
Journal of Clinical Pathways
News
08/26/2022

Yvette C Terrie

Yvette C Terrie
Findings from a recent study suggest that neither PD-1 nor its ligands represent relevant targets for mantle cell lymphoma treatment, however, age may impact the efficiency of immune checkpoint inhibitors.
Findings from a recent study suggest that neither PD-1 nor its ligands represent relevant targets for mantle cell lymphoma treatment, however, age may impact the efficiency of immune checkpoint inhibitors.
Findings from a recent study...
08/26/2022
Journal of Clinical Pathways
News
08/24/2022

Yvette C Terrie

Yvette C Terrie
Findings from a recent study confirmed the prognostic value of immunoglobulin heavy chain mutational status at diagnosis for overall survival and time to first treatment in patients with chronic lymphocytic leukemia.
Findings from a recent study confirmed the prognostic value of immunoglobulin heavy chain mutational status at diagnosis for overall survival and time to first treatment in patients with chronic lymphocytic leukemia.
Findings from a recent study...
08/24/2022
Journal of Clinical Pathways
News
08/18/2022

Yvette C Terrie

Yvette C Terrie
A real-world analysis of patient-reported outcomes in CLL/SLL revealed that quality-of-life scores remained stable over the first 12 months of treatment.
A real-world analysis of patient-reported outcomes in CLL/SLL revealed that quality-of-life scores remained stable over the first 12 months of treatment.
A real-world analysis of...
08/18/2022
Journal of Clinical Pathways
News
08/17/2022

Yvette C Terrie

Yvette C Terrie
The number of percutaneous and open procedures as well as reimbursement per procedure have progressively expanded from 2000 to 2019, according to a recent study.
The number of percutaneous and open procedures as well as reimbursement per procedure have progressively expanded from 2000 to 2019, according to a recent study.
The number of percutaneous and...
08/17/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement